Kentucky, Alaska and Alabama are the three states where weight loss drugs are most used, and Hawaii, Arizona and Colorado sit at the other end of the spectrum, a report has revealed. Glucagon-like ...

Dr. Ellen Morrow came into the studio to chat with Kari about the options people have when deciding between bariatric surgery ...

Options Medical Weight Loss, the nation's premier medical weight loss clinic, is proud to announce the grand opening of its new state-of-the-art clinic in Upper Arlington, Ohio, with a public ...

Axios Visuals Budget pressures have kept all but 13 states from covering GLP-1 drugs for weight loss through their Medicaid programs, a new report from KFF shows. Why it matters: The restrictive ...

A systematic review of randomized controlled trials (RCTs) found that weight-loss interventions were associated with improvements in some polycystic ovary syndrome (PCOS) symptoms, including ...

The weight-loss drug users and doctors whom The Times spoke to for this ... that have been studied as maintenance doses in ...

Geoff Cook, CEO of Noom, said 90% of subscribers using its weight-loss program are choosing the compounded version of the drugs. "We suspect that some patients may want branded product, but challenges ...

Always speak with your doctor before starting any new supplement or exercise regimen. Ro’s weight loss program is called the ...

Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an ...

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the presentation of two abstracts at Obesity Week 2024, the annual meeting of The Obesity Society.

Lifestyle management in polycystic ovary syndrome (PCOS) needs to reduce weight stigma, because for some people living with it, overly focusing on weight loss can negatively impact their mental health ...